XNASAHCO
Market cap1.36bUSD
Jan 10, Last price
10.14USD
1D
0.40%
1Q
0.50%
IPO
1.40%
Name
Adapthealth Corp
Chart & Performance
P/E
—
P/S
0.43
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
33.88%
Rev. gr., 5y
56.10%
Revenues
3.20b
+7.73%
Net income
-679m
L
CFO
481m
+28.57%
Earnings
Feb 25, 2025
Profile
AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. is headquartered in Plymouth Meeting, Pennsylvania.
IPO date
Feb 21, 2018
Employees
10,900
Domiciled in
US
Incorporated in
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||
Revenues | 3,200,177 7.73% | 2,970,595 21.02% | ||||||
Cost of revenue | 2,910,704 | 2,734,494 | ||||||
Unusual Expense (Income) | ||||||||
NOPBT | 289,473 | 236,101 | ||||||
NOPBT Margin | 9.05% | 7.95% | ||||||
Operating Taxes | (49,004) | 24,769 | ||||||
Tax Rate | 10.49% | |||||||
NOPAT | 338,477 | 211,332 | ||||||
Net income | (678,895) -1,079.42% | 69,316 -55.62% | ||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | (29,275) | (13,382) | ||||||
BB yield | 2.99% | 0.50% | ||||||
| Debt | ||||||||
Debt current | 130,152 | 67,212 | ||||||
Long-term debt | 2,349,556 | 2,402,167 | ||||||
Deferred revenue | (137,928) | |||||||
Other long-term liabilities | 302,093 | 344,004 | ||||||
Net debt | 2,401,590 | 2,419,379 | ||||||
| Cash flow | ||||||||
Cash from operating activities | 480,666 | 373,867 | ||||||
CAPEX | (337,463) | (391,423) | ||||||
Cash from investing activities | (357,278) | (411,171) | ||||||
Cash from financing activities | (92,528) | (66,051) | ||||||
FCF | 307,948 | 73,110 | ||||||
| Balance | ||||||||
Cash | 77,132 | 46,272 | ||||||
Long term investments | 986 | 3,728 | ||||||
Excess cash | ||||||||
Stockholders' equity | (640,015) | 41,602 | ||||||
Invested Capital | 4,741,818 | 4,688,357 | ||||||
ROIC | 7.18% | 4.50% | ||||||
ROCE | 7.06% | 4.89% | ||||||
| EV | ||||||||
Common stock shares outstanding | 134,418 | 138,988 | ||||||
Price | 7.29 -62.07% | 19.22 -21.42% | ||||||
Market cap | 979,907 -63.32% | 2,671,349 -17.91% | ||||||
EV | 3,389,713 | 5,097,329 | ||||||
EBITDA | 710,067 | 587,279 | ||||||
EV/EBITDA | 4.77 | 8.68 | ||||||
Interest | 130,299 | 109,414 | ||||||
Interest/NOPBT | 45.01% | 46.34% | ||||||